FDA cleared the BAROguard Donor Lung Preservation System from Paragonix Technologies, Inc. on Jan 30, 2026 under K254305, a special 510(k). The device falls under product code KDN, System, Perfusion, Kidney, regulated at 21 CFR 876.5880 as a Class 2 device. The review panel was Gastroenterology, Urology.

FDA logged the submission as received on Dec 31, 2025. The decision came 30 days later, inside the 90 FDA-day goal for a 510(k).

This is the only decision on file for Paragonix Technologies, Inc. in the last 12 months of the tracker.